285 related articles for article (PubMed ID: 32004538)
1. Development of 3D Printed Tablets by Fused Deposition Modeling Using Polyvinyl Alcohol as Polymeric Matrix for Rapid Drug Release.
Wei C; Solanki NG; Vasoya JM; Shah AV; Serajuddin ATM
J Pharm Sci; 2020 Apr; 109(4):1558-1572. PubMed ID: 32004538
[TBL] [Abstract][Full Text] [Related]
2. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
3. Improving drug release rate, drug-polymer miscibility, printability and processability of FDM 3D-printed tablets by weak acid-base interaction.
Patel NG; Serajuddin ATM
Int J Pharm; 2023 Feb; 632():122542. PubMed ID: 36566823
[TBL] [Abstract][Full Text] [Related]
4. Development of FDM 3D-printed tablets with rapid drug release, high drug-polymer miscibility and reduced printing temperature by applying the acid-base supersolubilization (ABS) principle.
Patel NG; Serajuddin ATM
Int J Pharm; 2021 May; 600():120524. PubMed ID: 33775724
[TBL] [Abstract][Full Text] [Related]
5. Defined drug release from 3D-printed composite tablets consisting of drug-loaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler.
Tagami T; Nagata N; Hayashi N; Ogawa E; Fukushige K; Sakai N; Ozeki T
Int J Pharm; 2018 May; 543(1-2):361-367. PubMed ID: 29605693
[TBL] [Abstract][Full Text] [Related]
6. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
7. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
[TBL] [Abstract][Full Text] [Related]
8. Drug Incorporation into Polymer Filament Using Simple Soaking Method for Tablet Preparation Using Fused Deposition Modeling.
Tagami T; Kuwata E; Sakai N; Ozeki T
Biol Pharm Bull; 2019; 42(10):1753-1760. PubMed ID: 31582663
[TBL] [Abstract][Full Text] [Related]
9. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
10. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets.
Goyanes A; Kobayashi M; Martínez-Pacheco R; Gaisford S; Basit AW
Int J Pharm; 2016 Nov; 514(1):290-295. PubMed ID: 27863674
[TBL] [Abstract][Full Text] [Related]
11. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
12. Preparation of Filaments and the 3D Printing of Dronedarone HCl Tablets for Treating Cardiac Arrhythmias.
Matijašić G; Gretić M; Kezerić K; Petanjek J; Vukelić E
AAPS PharmSciTech; 2019 Sep; 20(8):310. PubMed ID: 31520243
[TBL] [Abstract][Full Text] [Related]
13. Processability of poly(vinyl alcohol) Based Filaments With Paracetamol Prepared by Hot-Melt Extrusion for Additive Manufacturing.
Macedo J; Samaro A; Vanhoorne V; Vervaet C; Pinto JF
J Pharm Sci; 2020 Dec; 109(12):3636-3644. PubMed ID: 32949563
[TBL] [Abstract][Full Text] [Related]
14. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages.
Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY
AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916
[TBL] [Abstract][Full Text] [Related]
15. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
[TBL] [Abstract][Full Text] [Related]
16. 3D Printing of Metformin HCl PVA Tablets by Fused Deposition Modeling: Drug Loading, Tablet Design, and Dissolution Studies.
Ibrahim M; Barnes M; McMillin R; Cook DW; Smith S; Halquist M; Wijesinghe D; Roper TD
AAPS PharmSciTech; 2019 May; 20(5):195. PubMed ID: 31119403
[TBL] [Abstract][Full Text] [Related]
17. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.
Obeid S; Madžarević M; Ibrić S
Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830
[TBL] [Abstract][Full Text] [Related]
18. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
[TBL] [Abstract][Full Text] [Related]
19. Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.
Serajuddin ATM
ADMET DMPK; 2023; 11(1):33-55. PubMed ID: 36778904
[TBL] [Abstract][Full Text] [Related]
20. Amorphous solid dispersion of a binary formulation with felodipine and HPMC for 3D printed floating tablets.
Mora-Castaño G; Millán-Jiménez M; Niederquell A; Schönenberger M; Shojaie F; Kuentz M; Caraballo I
Int J Pharm; 2024 Jun; 658():124215. PubMed ID: 38740104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
